Overview

Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

Status:
Unknown status

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine effects of combination therapy with rosuvastatin and fenofibrate on atheromatous plaques and its tissue characteristics of de novo coronary lesions with intermediate stenosis in patient with coronary artery disease, compared with rosuvastatin alone therapy.

Phase:

Phase 4

Details

Lead Sponsor:

Gachon University Gil Medical Center

Collaborator:

Daewoong Pharmaceutical Co. LTD.

Treatments:

Fenofibrate
Rosuvastatin Calcium